Complexities of Covishield Vaccine on COVID-Positive History Family in India after the Second (Booster) Dose

Complexities of Covishield Vaccine on COVID-Positive History Family in India after the Second (Booster) Dose

COVID-19 epidemic severely affects the social life of people living in India. The best solution to the COVID-19 problem is the vaccination of the people. In India, COVID-19 vaccination started from January 16, 2021, mainly with the Covishield vaccine. In this study, the COVID-positive history family...

Full description

Bibliographic Details
Main Authors:	Parikshit Gautam Jamdade, Shrinivas Gautamrao Jamdade
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2022-01-01
Series:	CHRISMED Journal of Health and Research
Subjects:	covid-19 virus covishield side effects vaccination vaccines
Online Access:	http://www.cjhr.org/article.asp?issn=2348-3334;year=2022;volume=9;issue=4;spage=279;epage=281;aulast=Jamdade

Similar Items

COVISHIELD vaccine-induced thyroiditis: a case report
by: J. Sachin, et al.
Published: (2023-12-01)

Atypical facial onset Guillain-Barré syndrome following first dose of COVISHIELD vaccine
by: R.V. Aravinda, et al.
Published: (2021-09-01)

A Cross-sectional Study to Assess the Incidence of Adverse Drug Reactions to the Covishield Vaccine among Healthcare Workers of a Tertiary Care Government Institute in North India
by: Kamal Kant TRIVEDI, et al.
Published: (2023-06-01)

Adverse effects after first and second dose of covishield and covaxin: A longitudinal study
by: Amit Mittal, et al.
Published: (2022-01-01)

Side Effects Following Administration of the First Dose of Oxford-AstraZeneca’s Covishield Vaccine in Bangladesh: A Cross-Sectional Study
by: Nishat Jahan, et al.
Published: (2021-10-01)

Acute bilateral central serous chorioretinopathy in a young male after the first dose of Oxford/AstraZeneca AZD1222 (Covishield) vaccine
by: Meenakshi Sindhu, et al.
Published: (2023-01-01)

Harada-like syndrome post-Covishield vaccination: A rare adverse effect
by: Yogya Reddy, et al.
Published: (2022-01-01)

Covishield vaccination and pulmonary thromboembolism: A coincidence or a causal association?
by: Rijal Divas, et al.
Published: (2023-06-01)

COVID-19 vaccines portray the bright side of human creativity, but it means nothing until they prove their worth: A Study on Seroconversion after the first Dose of Covishield vaccine in central Kerala
by: Sangeetha Merrin Varghese, et al.
Published: (2022-01-01)

Facial Angioedema after the first dose of Covishield (adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccine): follow-up after the second and third booster doses
by: Walter de Araujo Eyer-Silva, et al.
Published: (2022-05-01)

Heterologous Booster Dose with CORBEVAX following Primary Vaccination with COVISHIELD Enhances Protection against SARS-CoV-2
by: Shashidhar Jaggaiahgari, et al.
Published: (2022-12-01)

Semen characteristics of individuals before and after Covishield™ vaccination
by: Huidrom Yaiphaba Meitei, et al.
Published: (2022-09-01)

Post-vaccination symptoms of covishield vaccine among frontline workers of a tertiary care center in Pathanamthitta District
by: Sahya S Dev, et al.
Published: (2023-01-01)

A study to determine adverse event following immunization using COVISHIELD vaccine for prevention of COVID-19 infection in a field practice area of urban health center
by: Sarika P Patil, et al.
Published: (2022-06-01)

Adverse events following immunization to booster dose (precautionary dose) of COVID-19 vaccine among health-care professionals in a tertiary care teaching institute
by: Kandula Chaitanya, et al.
Published: (2023-06-01)

Incidence of early adverse events following covishield (ChAdOx1 nCoV-19) vaccination: A prospective study
by: Gajanan D Velhal, et al.
Published: (2022-01-01)

A rare case of bilateral optic neuritis post-Covishield (ChAdOx1-S [recombinant]) vaccination
by: Tanie Natung, et al.
Published: (2023-01-01)

Modeling and prediction of COVID-19 spread in the Philippines by October 13, 2020, by using the VARMAX time series method with preventive measures
by: Parikshit Gautam Jamdade, et al.
Published: (2021-01-01)

Covishield™ (ChAdOx1) vaccine effectiveness and epidemiological risk factors of COVID-19 infection among frontline workers during second wave of COVID-19 pandemic, New Delhi: A case–control study
by: Kiran Kumar Maramraj, et al.
Published: (2022-01-01)

Profile of adverse events following COVID-19 vaccination: Insights from Covishield, Covaxin, and Corbevax beneficiaries in India
by: Shivaji B. Kashte, et al.
Published: (2023-01-01)

Immunogenicity of SARS-CoV-2 vaccines BBV152 (COVAXIN®) and ChAdOx1 nCoV-19 (COVISHIELD™) in seronegative and seropositive individuals in India: a multicentre, nonrandomised observational studyResearch in context
by: Mangaiarkarasi S. Asokan, et al.
Published: (2024-03-01)

Management of adverse events post-COVID-19 vaccination with Covaxin and Covishield: A literature review
by: Ayush Kumar, et al.
Published: (2022-01-01)

COVID-19 : Embolie Pulmonaire aigue sous le vaccin Covishield à l’Hôpital du Mali Aout 2021.
by: D Traore, et al.
Published: (2023-06-01)

“Covishield and Covaxin” – India's contribution to global COVID-19 pandemic
by: Sunil Kumar Raina, et al.
Published: (2021-01-01)

Self-reported side effects of COVID-19 vaccines among health professions students in India
by: Md Anwarul Azim Majumder, et al.
Published: (2024-04-01)

Vaccine distribution for COVID-19 and equity issues in India
by: J S Thakur, et al.
Published: (2021-01-01)

Quantitative estimation of anti-spike SARS-CoV-2 IgG antibody response after covishield vaccination in healthcare workers
by: Megha Goyal, et al.
Published: (2022-01-01)

Role of vaccination in COVID-19
by: Himamtrao Saluba Bawaskar, et al.
Published: (2022-01-01)

Vaccination and COVID-19 infection among adults aged 45 years and above in a North-Eastern state of India
by: Vanlalduhsaki, et al.
Published: (2022-01-01)

A study to describe the pattern of cutaneous adverse effects of COVID-19 vaccines (Covishield and Covaxin)
by: Neerja Saraswat, et al.
Published: (2023-01-01)

Seroconversion Rate After SARS-CoV-2 Infection and Two Doses of Either ChAdOx1-nCOV COVISHIELD™ or BBV-152 COVAXIN™ Vaccination in Renal Allograft Recipients: An Experience of Two Public and Private Tertiary Care Center
by: Narayan Prasad, et al.
Published: (2022-06-01)

Drivers for COVID 19 vaccine hesitancy among breastfeeding women in Eastern tribal state, India
by: Kiran Trivedi, et al.
Published: (2023-01-01)

Exploratory analysis of cost of Covid-19 vaccines in India
by: Singh Netra Pal, et al.
Published: (2022-01-01)

Drive-in Vaccination against COVID-19 in India
by: Lalithambigai Chellamuthu, et al.
Published: (2021-12-01)

Effectiveness of coronavirus disease-19 vaccination on disease transmission, hospitalization, and clinical outcomes in adults in North India
by: Shah Kshitij Darshan
Published: (2021-01-01)

COVID vaccines: A step towards ending the pandemic
by: Atul Kakar, et al.
Published: (2021-01-01)

An Analysis of the COVID-19 Vaccination Campaign in India
by: Gulshan R Bandre, et al.
Published: (2023-03-01)

Prevalence and determinants of adverse events following ChAdOx1 nCoV-19 vaccination (COVISHIELD) – A retrospective cohort study among healthcare workers in central Karnataka, India
by: Shubha B Davalagi, et al.
Published: (2023-01-01)

Pattern of Adverse Drug Reactions to Covishield Vaccine among the Faculty of a Tertiary Care Teaching Hospital in Jaipur City
by: Rupa Kapadia; Monica Jain; Lokendra Sharma; Kopal Sharma
Published: (2023-07-01)

Effectiveness of BBV152/Covaxin and AZD1222/Covishield vaccines against severe COVID-19 and B.1.617.2/Delta variant in India, 2021: a multi-centric hospital-based case-control study
by: Tarun Bhatnagar, et al.
Published: (2022-09-01)